BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2184 participants.
Also called NCT07363161
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,184 participants
- Sponsor
- Registry
-
NCT07363161
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany, Switzerland
- Registry status
- Recruiting
Technical summary
Registry record NCT07363161. Randomized; no masking; primary purpose treatment. Start 2026-06-17 (actual); primary completion 2027-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD)
- Acronym
- BASKET BALL
- Intervention (Device)
- PCI (percutaneous coronary intervention)
- Intervention (Device)
- PCI
- Lead sponsor
- B. Braun Melsungen AG
Record details
- Record id
cardio:ct-nct07363161- Content hash
7d576c696fec10d13e73d2c71c6c3dabcbef9ab0c654bc1fa8086925974ad7d2